Value-Based Healthcare: Lessons from a HEOR Expert | BioPharma Unscripted! Ep.7

Value-Based Healthcare: Lessons from a HEOR Expert | BioPharma Unscripted! Ep.7

Join Marcus Metcalfe as he speaks with Colette Mankowski, a veteran in Health Economics, Outcomes Research & Market Access with over 25 years of industry experience. In this candid conversation, Colette shares her unconventional journey into health economics, her career trajectory at Astellas, and her transition to independent consulting and mindfulness coaching.

Colette explains how she rose from medical information to become Executive Director of a 25-person regional HEOR team, while providing valuable insights on the evolution of health economics in pharmaceutical decision-making. She discusses why health economics should be integrated from Phase 1 trials, the importance of value-based evidence, and how the US pharmaceutical market is changing through the Inflation Reduction Act.

Beyond her technical expertise, Colette opens up about leadership values, the importance of psychological safety in teams, and how mindfulness techniques have transformed her approach to challenges in her career and personal life.

In this episode you'll learn:

How health economics evolved from an overlooked function to a strategic necessity
Why value-based pricing requires early HEOR integration in drug development
The challenges and rewards of transitioning to independent consulting
How mindfulness can address mental health challenges in high-pressure environments
Colette's plans to demystify HEOR and market access through educational content
The critical attributes of effective leadership in pharmaceutical organisations
How pharmaceutical companies can strategically use interim consultants

Chapters:
00:00 Introduction and reconnection
01:28 Colette's unconventional entry into pharma
03:45 Career trajectory at Astellas
05:30 The evolution of health economics in pharma
07:55 Explaining the importance of early HEOR integration
10:42 Value-based pricing and evidence generation
12:35 Leadership influences and psychological safety
15:20 The challenge of failure in pharmaceutical development
17:30 US healthcare system and regulatory changes
19:15 Transition to interim consulting
21:08 Mental health challenges in career transitions
22:45 Introduction to mindfulness techniques
24:30 Demystifying health economics through content
27:10 Final thoughts on connection and transformation

Connect with Marcus and Elucid8: https://www.linkedin.com/in/marcus-metcalfe-8938a35/ Marcus helps US & European Biotech & Pharmaceutical clients by providing Interim/Fractional & Advisory consultants for operational & strategic needs.

I also work selective Executive Search (perm) projects.

I have helped Clients when there is no headcount, when they can't find the right permanent candidate, when they have a spike in business, as an alternative to an external vendor or for those simply needing an extra pair of hands.

If you need a partner with an extensive network in HEOR and Market Access - this is his sweet spot.

He has placed over 120 HEOR and Market Access candidates during my time across US and Europe.

With his business partners, he covers the below functional areas.

• Biometrics • Business Development
• Clinical Research • Drug safety & Product safety
• Engineering • Health Economics
• Medical Affairs • Market Access
• Regulatory Affairs • Compliance/Quality Assurance
• Marketing & Medical • Scientific & Preclinical
• Communications

Sponsor Message

This episode is brought to you by www.elucid8.co - Connecting Talent, Strategy, and Investment to Transform Life Sciences

Podcast produced by www.podforge.co.uk